InvestorsHub Logo
Followers 91
Posts 11310
Boards Moderated 0
Alias Born 06/06/2014

Re: anders2211 post# 258676

Saturday, 07/11/2020 4:53:07 PM

Saturday, July 11, 2020 4:53:07 PM

Post# of 459967
Yes: Sonoma is instructive even if not in how biostock posed it. The stock went up 200% (not 300%), and only for a few hours, and only by $20mm in market cap. That is about $0.33 for us. The market didn't assign much value to its news, and for only an eye blink. The general market realized this was not a drug but a disinfectant that is not much better than current disinfectants and certainly not as cost effective. There are many disinfectants in your local supermarket that will dismantle a coronavirus pretty quickly, including the cheap stuff they wipe your cart with.

Our 200% rise would mean an additional $600MM in value. We're developing an experimental drug that, if successful in clinical testing, could have significant medical and economic superiority to current treatments in many indications, And we have a current market cap of around $300MM. The market for AVXL gives and takes away $20MM in value in a normal week. Will we go up $600MM in value, only to give it up the next day? No.

Would it go up $XMM amount and stay there? No to that too. Stocks are volatile.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News